Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-03

Clinical Trial Update: Human Laboratory Study of ASP8062 for Alcohol Use Disorder [Phase 2]

View source ↗

Summary

A Phase 2 human laboratory study of ASP8062 for alcohol use disorder has completed, with results posted on 2024-12-03.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASP8062

Snippet

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA) | Conditions: Alcohol Use Disorder, Alcohol Drinking | Phase 2 | Status: COMPLETED | Results posted: 2024-12-03